Avanos Medical, Inc.
AVNS
$13.11
-$0.01-0.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 701.20M | 699.90M | 692.50M | 689.20M | 687.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 701.20M | 699.90M | 692.50M | 689.20M | 687.80M |
| Cost of Revenue | 347.30M | 334.00M | 319.70M | 312.90M | 306.50M |
| Gross Profit | 353.90M | 365.90M | 372.80M | 376.30M | 381.30M |
| SG&A Expenses | 325.80M | 329.90M | 327.00M | 324.40M | 331.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -400.00K | 3.10M | 200.00K | 2.00M | 3.80M |
| Total Operating Expenses | 684.30M | 676.10M | 657.20M | 650.10M | 654.00M |
| Operating Income | 16.90M | 23.80M | 35.30M | 39.10M | 33.80M |
| Income Before Tax | -66.20M | -487.90M | -477.20M | -395.10M | -403.30M |
| Income Tax Expenses | 6.70M | -19.30M | -15.90M | -14.90M | -17.00M |
| Earnings from Continuing Operations | -72.90 | -468.60 | -461.30 | -380.20 | -386.30 |
| Earnings from Discontinued Operations | -- | -300.00K | -1.90M | -4.40M | -5.80M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.90M | -468.90M | -463.20M | -384.60M | -392.10M |
| EBIT | 16.90M | 23.80M | 35.30M | 39.10M | 33.80M |
| EBITDA | 55.80M | 63.90M | 77.70M | 82.80M | 79.30M |
| EPS Basic | -1.57 | -10.18 | -10.06 | -8.36 | -8.52 |
| Normalized Basic EPS | 0.17 | 0.25 | 0.39 | 0.46 | 0.36 |
| EPS Diluted | -1.58 | -10.19 | -10.07 | -8.38 | -8.54 |
| Normalized Diluted EPS | 0.16 | 0.25 | 0.39 | 0.46 | 0.36 |
| Average Basic Shares Outstanding | 185.20M | 184.80M | 184.40M | 184.00M | 184.10M |
| Average Diluted Shares Outstanding | 185.90M | 185.50M | 185.70M | 185.70M | 185.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |